Advertisement

Im Focus Onkologie

, Volume 21, Issue 5, pp 59–67 | Cite as

Kolonkarzinom-Update

Darmkrebs — das Neueste in Diagnostik und Therapie

  • Christoph Holmer
  • Martin E. Kreis
Gastroonkologie Zertifizierte Fortbildung
  • 209 Downloads

Zusammenfassung

Das kolorektale Karzinom hat nicht an epidemiologischer Relevanz verloren. Nach wie vor ist es bei Männern die zweithäufigste, bei Frauen die dritthäufigste krebsbedingte Todesursache. Erfahren Sie hier, was sich in den letzten Jahren in puncto Diagnostik und Therapie getan hat.

Literatur

  1. 1.
    Bericht zum Krebsgeschehen in Deutschland 2016. Zentrum für Krebsregisterdaten im Robert Koch-Institut (Hrsg). Berlin; 2016.Google Scholar
  2. 2.
    Majek O et al. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 2012;106(11):1875–80.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    S3-Leitlinie kolorektales Karzinom; Stand: 30.11.2017; AWMF-Registernummer: 021/007OL.Google Scholar
  4. 4.
    Haug U et al. Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended? Gut. 2017;66(7):1262–1267.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee JK et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    http://www.kbv.de/html/1150_28517.php. Zugegriffen am 06.05.2017
  7. 7.
    Imperiale TF et al. Multitarget stool DNA testing for colorectal cancer screening. N Engl J Med. 2014;370(14):1287–97.CrossRefPubMedGoogle Scholar
  8. 8.
    Brenner H et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;371(2):184–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Church TR et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317–25.CrossRefPubMedGoogle Scholar
  10. 10.
    de Haan MC et al. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a metaanalysis. Eur Radiol. 2011;21(8):1747–63.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    El-Maraghi RH, Kielar AZ. CT colonography versus optical colonoscopy for screening asymptomatic patients for colorectal cancer a patient, intervention, comparison, outcome (PICO) analysis. Acad Radiol. 2009;16(5):564–71.CrossRefPubMedGoogle Scholar
  12. 12.
    Ragnhammar P et al. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol. 2001;40(2-3):282–308.CrossRefPubMedGoogle Scholar
  13. 13.
    Andre T et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Haller DG et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29(11):1465–71.CrossRefPubMedGoogle Scholar
  15. 15.
    Yothers G et al. Oxaliplatin as adjuvant therapyfor coloncancer:updatedresults of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol. 2011;29(28):3768–74.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Saltz LB et al. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803. J Clin Oncol. 2007;25(23):3456–61.CrossRefPubMedGoogle Scholar
  17. 17.
    Hohenberger W et al. Standardized surgery for colonic cancer: completen mesocolic excision and central ligation — technical notes and outcome. Colorectal Dis. 2009;11(4):354–64CrossRefPubMedGoogle Scholar
  18. 18.
    Bernhoff R et al. Improved survival after an educational project on colon cancer management in the county of Stockholm — A population based cohort study. Eur J Surg Oncol. 2015;41(11):1479–84.CrossRefPubMedGoogle Scholar
  19. 19.
    Bertelsen CA et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015;16(2):161–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Buunen M et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009;10(1):44–52.CrossRefPubMedGoogle Scholar
  21. 21.
    Fleshman J et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg. 2007;246(4):655–62.CrossRefPubMedGoogle Scholar
  22. 22.
    Green BL et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100(1):75–82.CrossRefPubMedGoogle Scholar
  23. 23.
    Heinrich S, Lang H. Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro primary surgery. Chirurg. 2014;85(1):17–23.CrossRefPubMedGoogle Scholar
  24. 24.
    Verwaal VJ et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–43.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Allgemein-, Viszeral- und GefäßchirurgieCharité — Universitätsmedizin Berlin, Campus Benjamin FranklinBerlinDeutschland
  2. 2.

Personalised recommendations